Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea. Celltrion Pharm, Inc. (KOSDAQ:A068760) operates as a subsidiary of Celltrion, Inc.
Metrics to compare | 068760 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship068760PeersSector | |
---|---|---|---|---|
P/E Ratio | 0.0x | 4.2x | −0.7x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.0x | 1.2x | 2.6x | |
Price / LTM Sales | 0.0x | 0.9x | 3.4x | |
Upside (Analyst Target) | 0.0% | 19.5% | 37.6% | |
Fair Value Upside | Unlock | 4.9% | 5.3% | Unlock |